Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Director | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,023 |
Reported balance
After 2026-02-17 transaction · row 1
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 7,562 · Balance 132,023 F1: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on February 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on February 17, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2026 Filed Feb 19, 2026 19:03 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 7,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001780880-26-000001 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,023 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on February 17, 2026. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 16:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 6,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001780880-25-000002 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,461 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on December 1, 2025. Read SEC document |
| September 01, 2025 Filed Sep 5, 2025 16:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 4,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-006120 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,252 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on September 1, 2025. Read SEC document |
| July 09, 2025 Filed Jul 10, 2025 20:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 36,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005377 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,282 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 18:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 4,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004386 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,051 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on June 1, 2025. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 17:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002001 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,971 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on March 1, 2025. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 4,500 | $6.93 | $31,184.10 |
DisclosureSEC source: 0001562180-25-000010 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,938 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 26, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 23, 2024 Filed Dec 27, 2024 16:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 4,500 | $6.98 | $31,415.40 |
DisclosureSEC source: 0001562180-24-008598 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,438 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 26, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 2,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-008090 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,938 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on December 1, 2024. Read SEC document |
| September 01, 2024 Filed Sep 10, 2024 18:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 2,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006759 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,937 F1 · shares: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on September 1, 2024. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 20,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005136 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,523 F1 · shares: Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 12,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005294 · primarydocument.xml · nonDerivative · entry 2 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,716 F2 · shares: Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 5,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005294 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,211 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on each of September 1, 2023, December 1, 2023, March 1, 2024 and June 1, 2024. Read SEC document |
| August 19, 2022 Filed Aug 19, 2022 16:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | PurchaseCommon Stock | 6,600 | $11.63 | $76,750.74 |
DisclosureSEC source: 0001562180-22-006235 · primarydocument.xml · nonDerivative · entry 2 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,405 Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 16:02 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | PurchaseCommon Stock | 8,400 | $11.69 | $98,196.00 |
DisclosureSEC source: 0001562180-22-006235 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,805 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 11,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005145 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,405 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 16:56 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004245 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,728 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| June 12, 2020 Filed Jun 17, 2020 19:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 5,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004566 · primarydocument.xml · nonDerivative · entry 1 Gallagher Duncan · CIK 0001780880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.